A detailed history of Wealthcare Advisory Partners LLC transactions in Dexcom Inc stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 17,103 shares of DXCM stock, worth $1.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
17,103
Previous 19,909 14.09%
Holding current value
$1.3 Million
Previous $2.26 Million 49.22%
% of portfolio
0.03%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$64.0 - $116.06 $179,584 - $325,664
-2,806 Reduced 14.09%
17,103 $1.15 Million
Q2 2024

Aug 09, 2024

SELL
$110.31 - $140.45 $37,174 - $47,331
-337 Reduced 1.66%
19,909 $2.26 Million
Q1 2024

Apr 15, 2024

BUY
$114.22 - $140.1 $2.31 Million - $2.84 Million
20,246 New
20,246 $2.81 Million
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $143,446 - $207,066
1,688 Added 53.66%
4,834 $547,000
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $1,527 - $1,883
-20 Reduced 0.63%
3,146 $253,000
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $160,864 - $314,417
2,366 Added 295.75%
3,166 $236,000
Q1 2022

Apr 15, 2022

BUY
$94.08 - $130.2 $6,773 - $9,374
72 Added 9.89%
800 $409,000
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $94,545 - $118,532
728 New
728 $97,000
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $27,536 - $36,696
-340 Closed
0 $0
Q1 2021

Apr 30, 2021

SELL
$84.79 - $104.74 $19,586 - $24,194
-231 Reduced 40.46%
340 $122,000
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $44,538 - $59,669
571 New
571 $211,000
Q2 2020

Jul 29, 2020

SELL
$62.68 - $105.34 $15,670 - $26,335
-250 Closed
0 $0
Q2 2019

Jul 30, 2019

BUY
$27.84 - $38.92 $6,960 - $9,730
250 New
250 $37,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.